EPA proposes removing 100 percent of lead pipes from US water system
Nov 30, 2023
Utility companies expected to cover most of the cost, but there is $15 billion available in the 2021 infrastructure law to help
Smaller, leadless pacemaker model gets FDA approval
By
Aaron Dorman
Jul 06, 2023
A new pacemaker that is smaller than a AAA battery and contains no lead wires just cleared a major administrative hurdle and could soon be an option for patients with slow or abnormal heart rhythms.
Defibrillator drones beat ambulances to the scene of cardiac arrest, new research shows
By
Aaron Dorman
Nov 28, 2023
Drones could offer emergency relief to heart attack sufferers faster than a traditional ambulance, a new study reveals.
Cutting social isolation, loneliness may lower mortality in people with obesity
Jan 24, 2024
The authors say that the findings support efforts to improve social isolation and loneliness.
Electronic socks bring seniors’ diabetes concerns to heel
By
Aaron Dorman
Apr 10, 2024
A new “electronic sock” equipped with sensors showed promise for helping with diabetes and circulation in feet, according to new research.
Having a sense of purpose can lower the risk of death
By
Lois A. Bowers
Dec 05, 2022
People with higher levels of purpose may have a lower risk of death from any cause, according to a study recently published in the journal Preventive Medicine.
Gender life expectancy gap increased from 2010 to 2021
Nov 13, 2023
The leading contributors to the widening gender life expectancy gap from 2019 to 2021 included COVID-19 and unintentional injuries.
Virtual reality interventions are suggested to have a positive effect on anticipatory anxiety symptoms and pain.
Clinicians and caregivers must keep pace with new pacemaker tech available for seniors: study
By
Aaron Dorman
Feb 06, 2024
A new survey classifies cardiac implantable electronic devices, or CIEDs, to account for advances such as leadless multi-chamber pacemaker models.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.